Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis
1. 系统已在2026-08-10 14:48:35对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/24002148
其他信息:
PMID: 24002148
作者: Michael Jarratt; William Jo Siu; Eiko Yamakawa; Nobuyuki Kodera; Radhakrishnan Pillai; ...
摘要: Objectives: To characterize the systemic exposure and pharmacokinetics of efinaconazole 10% solution and assess the potential for drug-drug interaction (DDI) in human volunteers and onychomycosis patients following topical administration.

